Anti-AKT1 (phospho S124) antibody [EPR17680]
- RabMAb
- Recombinant
- Lab Essentials
- 20ul selling size
- What is this?
Be the first to review this product! Submit a review
|
(8 Publications)
Rabbit Recombinant Monoclonal AKT1 phospho S124 antibody. Suitable for IP, ELISA, Dot, WB and reacts with Human, Mouse, Rat, Synthetic peptide samples. Cited in 8 publications.
View Alternative Names
PKB, RAC, AKT1, RAC-alpha serine/threonine-protein kinase, Protein kinase B, Protein kinase B alpha, Proto-oncogene c-Akt, RAC-PK-alpha, PKB alpha
- IP
Supplier Data
Immunoprecipitation - Anti-AKT1 (phospho S124) antibody [EPR17680] (AB183556)
Immunoprecipitation of AKT1 from 1mg of MCF7 (Human breast adenocarcinoma cell line) whole cell lysate achieved using ab183556 at 1/100 dilution.
Lane 1 : Input : 10μg of MCF7 whole cell lysate.
Lane 2 : MCF7 whole cell lysate following IP with ab183556.
Lane 3 : negative control : IP using Rabbit monoclonal IgG (ab172730) instead of ab183556 in MCF7 whole cell lysate.
Western blot was performed using ab183556 at 1/1000 dilution.
An Anti-Rabbit IgG (HRP), specific to the non-reduced form of IgG at 1/1500 was used as secondary antibody.
Blocking and dilution buffer and concentration : 5% NFDM/TBST. 10 second exposure.
All lanes:
Immunoprecipitation - Anti-AKT1 (phospho S124) antibody [EPR17680] (ab183556)
Predicted band size: 47 kDa,55 kDa
Observed band size: 56 kDa
false
- WB
Supplier Data
Western blot - Anti-AKT1 (phospho S124) antibody [EPR17680] (AB183556)
5% NFDM/TBST : Blocking and diluting buffer.
All lanes:
Western blot - Anti-AKT1 (phospho S124) antibody [EPR17680] (ab183556) at 1/1000 dilution
Lane 1:
MCF7 (Human breast adenocarcinoma cell line) whole cell lysate, untreated at 10 µg
Lane 2:
MCF7 whole cell lysate, treated with Alkaline Phosphatase at 10 µg
Secondary
All lanes:
Goat Anti-Rabbit IgG, (H+L),Peroxidase conjugated at 1/1000 dilution
Predicted band size: 55 kDa
Observed band size: 56 kDa
false
Exposure time: 15s
- WB
Supplier Data
Western blot - Anti-AKT1 (phospho S124) antibody [EPR17680] (AB183556)
5% NFDM/TBST : Blocking and diluting buffer.
All lanes:
Western blot - Anti-AKT1 (phospho S124) antibody [EPR17680] (ab183556) at 1/1000 dilution
Lane 1:
Human fetal brain tissue lysate at 10 µg
Lane 2:
Human fetal kidney tissue lysate at 10 µg
Lane 3:
Mouse brain tissue lysate at 10 µg
Lane 4:
Rat brain tissue lysate at 10 µg
Lane 5:
Rat heart tissue lysate at 10 µg
Lane 6:
RAW 264.7 (Mouse macrophage cells transformed with Abelson murine leukemia virus) whole cell lysate at 10 µg
Lane 7:
PC-12 (Rat adrenal gland pheochromocytoma) whole cell lysate at 10 µg
Secondary
All lanes:
Anti-Rabbit IgG (HRP), specific to the non-reduced form of IgG at 1/1000 dilution
Predicted band size: 55 kDa
Observed band size: 56 kDa
false
Exposure time: 3min
- WB
Supplier Data
Western blot - Anti-AKT1 (phospho S124) antibody [EPR17680] (AB183556)
5% NFDM/TBST : Blocking and diluting buffer.
All lanes:
Western blot - Anti-AKT1 (phospho S124) antibody [EPR17680] (ab183556) at 1/10000 dilution
Lane 1:
NIH/3T3 (Mouse embyro fibroblast cells) whole cell lysate, untreated at 10 µg
Lane 2:
NIH/3T3 whole cell lysate, treated with Alkaline Phosphatase at 10 µg
Secondary
All lanes:
Goat Anti-Rabbit IgG, (H+L),Peroxidase conjugated at 1/1000 dilution
Predicted band size: 55 kDa
Observed band size: 56 kDa
false
Exposure time: 3min
- WB
Supplier Data
Western blot - Anti-AKT1 (phospho S124) antibody [EPR17680] (AB183556)
5% NFDM/TBST : Blocking and diluting buffer.
All lanes:
Western blot - Anti-AKT1 (phospho S124) antibody [EPR17680] (ab183556) at 1/10000 dilution
Lane 1:
C6 (Rat glial tumor cells) whole cell lysate, untreated at 10 µg
Lane 2:
C6 whole cell lysate, treated with Alkaline Phosphatase at 10 µg
Secondary
All lanes:
Goat anti-rabbit IgG, (H+L), peroxidase conjugated at 1/1000 dilution
Predicted band size: 55 kDa
Observed band size: 56 kDa
false
Exposure time: 3min
- ELISA
Supplier Data
ELISA - Anti-AKT1 (phospho S124) antibody [EPR17680] (AB183556)
ELISA image showing specificity of ab183556 to AKT1 (phospho S124) peptide only.
Peptides concentration : 1000 ng/ml.
ab183556 working dilution : 1/1700.
Secondary antibody : Alkaline Phosphatase-conjugated AffiniPure Goat Anti-Rabbit IgG (H+L) at 1/2500.
- Dot
Supplier Data
Dot Blot - Anti-AKT1 (phospho S124) antibody [EPR17680] (AB183556)
Dot blot analysis of AKT1 (phospho S124) labeled with ab183556 at 1/1000 dilution.
Lane 1 : phospho peptide
Lane 2 : non phospho peptide
Goat Anti-Rabbit IgG (H+L)Peroxidase conjugated at 1/1000 was used as secondary antibody.
Exposure time : 3 minutes.
Blocking and Diluting buffer buffer and concentration : 5% NFDM/TBST
Related conjugates and formulations (1)
-
Anti-AKT1 (phospho S124) antibody [EPR17680] - BSA and Azide free
Reactivity data
Product details
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
AKT1 regulates a broad spectrum of cellular functions through signaling pathways. It is an important player in the phosphatidylinositol 3-kinase (PI3K) and AKT pathway forming part of a complex involved in promoting cell survival and growth. AKT1 interacts closely with other proteins such as mTOR influencing cellular metabolism and autophagy. The phosphorylation state of AKT1 is critical for its activity with modifications like p-AKT S473 impacting its interaction with cellular substrates.
Pathways
AKT1 participates in the PI3K/AKT/mTOR signaling cascade instrumental in cell proliferation and metabolism. AKT1 integrates signals from insulin and growth factors modulating pathways that control cell growth and glucose uptake. This pathway involves proteins like mTOR and phospho-AKT which coordinate cellular responses to external stimuli. AKT1’s phosphorylation at serine 473 and the involvement of AKT1 E17K a gain-of-function mutation influence these pathways significantly.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (8)
Recent publications for all applications. Explore the full list and refine your search
ACS omega 9:21426-21439 PubMed38764617
2024
Applications
Unspecified application
Species
Unspecified reactive species
Synapse (New York, N.Y.) 77:e22268 PubMed36941024
2023
Applications
Unspecified application
Species
Unspecified reactive species
Experimental and therapeutic medicine 25:169 PubMed37006880
2023
Applications
Unspecified application
Species
Unspecified reactive species
Cell reports 41:111891 PubMed36577384
2022
Applications
Unspecified application
Species
Unspecified reactive species
Frontiers in pharmacology 13:967141 PubMed36133816
2022
Applications
Unspecified application
Species
Unspecified reactive species
Journal of cell science 133: PubMed32938684
2020
Applications
Unspecified application
Species
Unspecified reactive species
International journal of molecular medicine 43:1747-1757 PubMed30720051
2019
Applications
Unspecified application
Species
Unspecified reactive species
Journal of cellular biochemistry 120:7115-7124 PubMed30378162
2018
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com